ArticleFrontiers in oncology2021

SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma.

Mu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.